Interferon-γ increases expression of the di/tri-peptide transporter, h-PEPT1, and dipeptide transport in cultured human intestinal monolayers

Pharmacological Research

Volumn 59, Issue 3, 2009, Pages 215-220

  Foster, David R ^a   Landowski, Christopher P ^b   Zheng, Xiaomei ^a   Amidon, Gordon L ^c   Welage, Lynda S ^c,d  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Caco 2 cells; h PEPT1; Interferon

Indexed keywords

DIPEPTIDE; GAMMA INTERFERON; GLYCYLSARCOSINE; MESSENGER RNA; PEPTIDE DERIVATIVE; PEPTIDE TRANSPORTER 1; PEPTIDOMIMETIC AGENT;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE ABSORPTION; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPERATURE DEPENDENCE; TRANSPORT KINETICS;

BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; DIPEPTIDES; ELECTRIC IMPEDANCE; HUMANS; INTERFERON-GAMMA; INTESTINAL ABSORPTION; MANNITOL; PERMEABILITY; RNA, MESSENGER; SYMPORTERS;

EID: 59349096097     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.11.001     Document Type: Article

References (36)

1. Oh D.-M., Han H.K., and Amidon G.L. Drug transport and targeting. In: Amidon G.L., and Sadee W. (Eds). Membrane transporters as drug targets (1999), Kluwer Academic/Plenum, New York 59-88
2. Brodin B., Nielsen C.U., Steffansen B., and Frokjaer S. Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT1. Pharmacol Toxicol 90 (2002) 285-296
3. Daniel H., and Kottra G. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch Eur J Physiol 447 (2003) 610-618
4. Adibi S.A. The oligopeptide transporter (Pept-1) in human intestine: biology and function. Gastroenterology 113 (1997) 332-340
5. Terada T., and Inui K. Peptide transporters: structure, function, regulation and applicatin for drug delivery. Curr Drug Metab 5 (2004) 85-94
6. Nielsen C.U., Brodin B., Jørgensen F.S., Frokjaer S., and Steffansen B. Human peptide transporters: therapeutic applications. Exp Opin Ther Patents 12 (2002) 1-23
7. Anand B.S., Patel J., and Mitra A.K. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2. J Pharmacol Exp Ther 304 (2003) 781-791
8. Irie M., Terada T., Sawada K., Saito H., and Inui K. Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells. J Pharmacol Exp Ther 298 (2001) 711-717
9. Adibi S.A. Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am J Physiol Gastrointest Liver Physiol 285 (2003) G779-G788
10. Nielsen C.U., and Brodin B. Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions. Curr Drug Targets 4 (2003) 373-388
11. Neudeck B.L., Foster D.R., Li Y., Gonzales J.P., and Welage L.S. The effects of thermal injury on transcellular permeability and intestinal P-glycoprotein in rats. Burns 29 (2003) 803-809
12. Hartmann G., Kim H., and Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 1 (2001) 189-199
13. Kalitsky-Szirtes J., Shayeganpour A., Brocks D.R., and Piquette-Miller M. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab Dispos 32 (2004) 20-27
14. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75 (2004) 163-189
15. Schoenborn J.R., and Wilson C.B. Regulation of Interferon-γ during innate and adaptive immune responses. Adv Immunol 96 (2007) 41-101
16. Matsuura T., and Fiocchi C. Cytokine production in the gastrointestinal tract during inflammation. In: Walker W., and Harmatz P.R. (Eds). Immunophysiology of the gut (1993), Academic Press, San Diego 145-163
17. Takahashi I., and Kiyono H. Gut as the largest immunologic tissue. JPEN J Parenter Enteral Nutr 23 (1999) 7-12
18. Colgan S.P., Morales V.M., Madara J.L., Polischuk J.E., Balk S.P., and Blumberg R.S. IFN-gamma modulates CD1d surface expression on intestinal epithelia. Am J Physiol 271 (1996) C276-C283
19. Colgan S.P., Parkos C.A., Matthews J.B., D'Andrea L., Awtrey C.S., Lichtman A.H., et al. Interferon-gamma induces a cell surface phenotype switch on T84 intestinal epithelial cells. Am J Physiol 267 (1994) C402-C410
20. Chu X.Y., Sanchez-Castano G.P., Higaki K., Oh D.M., Hsu C.P., and Amidon G.L. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter. J Pharmacol Exp Ther 299 (2001) 575-582
21. Sun D., Lennernas H., Welage L.S., Barnett J.L., Landowski C.P., Foster D., et al. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res 19 (2002) 1400-1416
22. Madara J.L., and Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83 (1989) 724-727
23. Berin M.C., Yang P.C., Ciok L., Waserman S., and Perdue M.H. Role for IL-4 in macromolecular transport across human intestinal epithelium. Am J Physiol 276 (1999) 1046-1052
24. Planchon S.M., Martins C.A., Guerrant R.L., and Roche J.K. Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 153 (1994) 5730-5739
25. Buyse M., Charrier L., Sitaraman S., Gewirtz A., and Merlin D. Interferon-gamma increases hPepT1-mediated uptake of di-tripeptides including the bacterial tripeptide fMLP in polarized intestinal epithelia. Am J Pathol 163 (2003) 1969-1977
26. Vavricka S.R., Musch M.W., Fujiya M., Kles K., Chang L., Eloranta J.J., et al. Tumor necrosis factor α and interferon-γ increase PepT1 expression and activity in human colon carcinoma cell line Caco-2/bbe and in mouse intestine. Pflugers Arch Eur J Physiol 452 (2006) 71-80
27. Behrens I., Walter K., Dantzig A.H., and Kissel T. Variation of peptide transporter (PepT1 and HPT1) expression in Caco-2 cells as a function of cell origin. J Pharm Sci 93 (2004) 1743-1754
28. Tanaka H., Miyamoto K.I., Morita K., Haga H., Segawa H., Shiraga T., et al. Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury. Gastroenterology 114 (1998) 714-723
29. Thamotharan M., Bawani S.Z., Zhou X., and Adibi S.A. Functional and molecular expression of intestinal oligopeptide transporter (Pept-1) after a brief fast. Metabolism 48 (1999) 681-684
30. Ihara T., Tsujikawa T., Fujiyama Y., and Bamba T. Regulation of PepT1 peptide transporter expression in the rat small intestine under malnourished conditions. Digestion 61 (2000) 59-67
31. Gangopadhyay A., Thamotharan M., and Adibi S. Regulation of oligopeptide transporter (PepT-1) in experimental diabetes. Am J Physiol 283 (2002) G133-G138
32. Bikhazi A.B., Skoury M.M., Zwainy D.S., Jurjus A.R., Kreydivyeh S.I., Smith D.E., et al. Effect of diabetes mellitus and insulin on the regulation of the PepT 1 symporter in rat jejunum. Mol Pharm 1 (2004) 300-308
33. Merlin D., Si-Tahar M., Sitaraman S.V., Eastburn K., Williams I., Liu X., et al. Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules. Gastroenterology 120 (2001) 1666-1679
34. Shu H.J., Takeda H., Shinzawa H., Takahashi T., and Kawata S. Effect of lipopolysaccharide on peptide transporter 1 expression in rat small intestine and its attenuation by dexamethasone. Digestion 65 (2002) 21-29
35. Sun B.W., Zhao X.C., Wang G.J., Li N., and Li J.S. Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management. World J Gastroenterol 9 (2003) 808-812
36. Foster D.R., and Zheng X. Cephalexin inhibits N-formylated peptide transport and intestinal hyperpermeability in Caco2 cells. J Pharmacy Pharm Sci 10 (2007) 330-341